Concepedia

Zhiqing Zhan

ZZ

Statistics

Publications

11

Citations

489

H-Index

10

Active since

1994

Affiliations

National Cancer Institute(Current)

Shanghai Jiao Tong University

Renji Hospital

State Key Laboratory of Oncogene and Related Genes

National Institutes of Health

Zhiqing Zhan is an author at National Cancer Institute specializing in oncology, medicine, and gene expression.

ORCID

Publications per year

1994–2025

11

Publications

11

Controlled trial of dexverapamil, a modulator of multidrug resistance, in lymphomas refractory to EPOCH chemotherapy.

Wyndham H. Wilson, Susan E. Bates, Antonio Tito Fojo et al. · Journal of Clinical Oncology · 1995 · 124 citations

, , +13

Aberrant Promoter Methylation of the <i>ABCG2</i> Gene in Renal Carcinoma

Kenneth K.W. To, Zhiqing Zhan, Susan E. Bates · Molecular and Cellular Biology · 2006 · 119 citations · Full text

, , +17

Humoral immune response of BBIBP COVID‐19 vaccination before and after the booster immunization

Zhangkai J. Cheng, Huimin Huang, Peiyan Zheng et al. · Allergy · 2022 · 54 citations · Full text

, , +17

Downregulation of mdr-1 expression by 8-Cl-cAMP in multidrug resistant MCF-7 human breast cancer cells.

Stefania Scala, Alfredo Budillon, Zhiqing Zhan et al. · Journal of Clinical Investigation · 1995 · 44 citations · Full text

, , +11

Expression of mdr-1 in refractory lymphoma: quantitation by polymerase chain reaction and validation of the assay [published erratum appears in Blood 1995 Dec 15;86(12):4710]

Y-K. Kang, Zhiqing Zhan, Joanna Regis et al. · Blood · 1995 · 42 citations · Full text

, , +12

1–5 of 11